Epilepsy, sex hormones and antiepileptic drugs in female patients

References

• Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch. Neurol.43, 341–346 (1986).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N. Engl. J. Med.329, 1383–1388 (1993).
   PubMed Web of Science ®Google Scholar
• Klüver H, Bucy PC, Klüver H, Bucy PC. Preliminary analysis of functions of the temporal lobes in monkeys. J. Neuropsychiatry Clin. Neurosci.9, 606–620 (1939).
   Google Scholar
• Herzog AG, Fowler KM. Sexual hormones and epilepsy: threat and opportunities. Curr. Opin. Neurol.18, 167–172 (2005).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Taubøll E, Herzog AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs19, 207–223 (2005).
   PubMed Web of Science ®Google Scholar
• de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H. Endocrine effects of valproate in adolescent girls with epilepsy. Epilepsia48, 470–477 (2007).
   PubMed Web of Science ®Google Scholar
• Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet352, 1970–1973 (1998).
   PubMed Web of Science ®Google Scholar
• Dansky LV, Andermann E, Andermann F. Marriage and fertility in epileptic patients. Epilepsia21, 261–271 (1980).
   PubMed Web of Science ®Google Scholar
• Webber MP, Hauser WA, Ottman R, Annegers JF. Fertility in persons with epilepsy: 1935–1974. Epilepsia27, 746–752 (1986).
   PubMed Web of Science ®Google Scholar
• Hamed SA. Neuroendocrine hormonal conditions in epilepsy: relationship to reproductive and sexual functions. Neurologist14, 157–169 (2008).
   PubMed Web of Science ®Google Scholar
• Morrell MJ, Giudice L, Flynn KL et al. Predictors of ovulatory failure in women with epilepsy. Ann. Neurol.52, 704–711 (2002).
   PubMed Web of Science ®Google Scholar
• Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia44, 11–20 (2002).
   Google Scholar
• Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology57, 2133–2135 (2002).
   Web of Science ®Google Scholar
• Herzog AG, Coleman AE, Jacobs AR et al. Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Ann. Neurol.54, 625–637 (2003).
   PubMed Web of Science ®Google Scholar
• Klein P, Serje A, Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia42, 1584–1589 (2001).
   PubMed Web of Science ®Google Scholar
• Harden CL, Koppel BS, Herzog AG, Nikolov BG, Hauser WA. Seizure frequency is associated with age at menopause in women with epilepsy. Neurology61, 451–455 (2003).
   PubMed Web of Science ®Google Scholar
• Hamed SA, Hamed EA, Shokry M, Omar H, Abdellah MM. The reproductive conditions and lipid profile in females with epilepsy. Acta Neurol. Scand.115, 112–122 (2007).
   Google Scholar
• Bauer J, Isojärvi JI, Herzog AG et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J. Neurol. Neurosurg. Psychiatr.73, 121–125 (2002).
   PubMed Web of Science ®Google Scholar
• Stoffel-Wagner B, Bauer J, Flügel D, Brennemann W, Klingmüller D, Elger CE. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication. Epilepsia39, 1164–1173 (1998).
   PubMed Web of Science ®Google Scholar
• Morrell MJ. Epilepsy in women. Am. Fam. Physician66, 1489–1494 (2002).
   PubMed Web of Science ®Google Scholar
• Bilo L, Meo R, Nappi C et al. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia29, 612–619 (1988).
   PubMed Web of Science ®Google Scholar
• Nappi C, Meo R, Di Carlo C, Estraneo A, Bilo L. Reuced fertility and neuroendocrine dysfunction in women with epilepsy. Gynecol. Endocrinol.8, 133–145 (1994).
   PubMed Web of Science ®Google Scholar
• Scharfman HE, Kim M, Hintz TM, MacLusky NJ. Seizures and reproductive function: insights from female rats with epilepsy. Ann. Neurol.64, 687–697 (2008).
   PubMed Web of Science ®Google Scholar
• Edwards HE, Burnham WM, Ng MM, Asa S, MacLusky NJ. Limbic seizures alter reproductive function in the female rat. Epilepsia40, 1370–1377 (1999).
   PubMed Web of Science ®Google Scholar
• Feeney DM, Gullotta FP, Gilmore W. Hyposexuality produced by temporal lobe epilepsy in the cat. Epilepsia39, 140–149 (1998).
   PubMed Web of Science ®Google Scholar
• Sperling MR, Pritchard PB, Engel J, Daniel C, Sagel J. Prolactin in partial epilepsy: an indicator of limbic seizures. Ann. Neurol.20, 716–722 (1986).
   PubMed Web of Science ®Google Scholar
• Hum KM, Megna S, Burnham WM. The effects of right and left amygdala kindling on the female reproductive system in rats. Epilepsia50, 880–886 (2009).
   PubMed Web of Science ®Google Scholar
• Herzog AG. A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy. Neurology43, 1907–1910 (1993).
   PubMed Web of Science ®Google Scholar
• Löfgren E, Mikkonen K, Tolonen U et al. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication. Epilepsy Behav.10, 77–83 (2007).
   PubMed Web of Science ®Google Scholar
• Meo R, Bilo L, Nappi C et al. Derangement of the hypothalamic GnRH pulse generator in women with epilepsy. Seizure2, 241–252 (1993).
   PubMedGoogle Scholar
• Drislane FW, Coleman AE, Schomer DL et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology44, 306–310 (1994).
   PubMed Web of Science ®Google Scholar
• Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia36, 355–359 (1995).
   PubMed Web of Science ®Google Scholar
• Herzog AG. Menstrual disorders in women with epilepsy. Neurology66, S23–S28 (2006).
   PubMed Web of Science ®Google Scholar
• Bazán AC, Montenegro MA, Cendes F, Min LL, Guerreiro CA. Menstrual cycle worsening of epileptic seizures in women with symptomatic focal epilepsy. Arq. Neuropsiquiatr.63, 751–756 (2005).
   PubMed Web of Science ®Google Scholar
• Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterization of reproductive endocrine disorders in women with epilepsy. J. Clin. Endocrinol. Metab.86, 2950–2956 (2001).
   PubMed Web of Science ®Google Scholar
• Bilo L, Meo, R, Valentino R, Buscaino GA, Striano S, Nappi C. Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy. Fertil. Steril.55, 705–711 (1991).
   PubMed Web of Science ®Google Scholar
• Murialdo G, Magri F, Tamagno G et al. Seizure frequency and sex steroids in women with partila epilepsy on antiepileptic therapy. Epilepsia50, 1920–1926 (2009).
   PubMed Web of Science ®Google Scholar
• Svalheim S, Taubøll E, Bjørnenak T et al. Do women with epilepsy have increased frequency of menstrual disturbances? Seizure12, 529–533 (2003).
   PubMed Web of Science ®Google Scholar
• Spratt DI, Finkelstein JS, Butler JP, Badger TM, Crowley WF. Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men. J. Clin. Endocrinol. Metab.64, 1179–1186 (1987).
   PubMed Web of Science ®Google Scholar
• Herzog AG. A hypothesis to integrate partial seizures of temporal lobe origin and reproductive endocrine disorders. Epilepsy Res.3, 151–159 (1989).
   PubMed Web of Science ®Google Scholar
• Klüver H, Bucy PC, Klüver H, Bucy PC. Preliminary analysis of functions of the temporal lobes in monkeys. 1939. J. Neuropsychiatry Clin. Neurosci.9, 606–620 (1997).
   PubMed Web of Science ®Google Scholar
• Rao ML, Stefen H, Bauer J. Epileptic but not psychogenic seizures are accompained by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology49, 33–39 (1989).
   PubMed Web of Science ®Google Scholar
• Herzog AG. Polycystic ovarian syndrome in women with epilepsy: epileptic or iatrogenic? Ann. Neurol.39, 559–560 (1996).
   PubMed Web of Science ®Google Scholar
• Daniele A, Azzoni A, Bizzi A, Rossi A, Gainotti G, Mazza S. Sexual behavior and hemispheric laterality of the focus in patients with temporal lobe epilepsy. Biol. Psychiatry42, 617–624 (1997).
   PubMed Web of Science ®Google Scholar
• Baird AD, Wilson SJ, Bladin PF, Saling MM, Reutens DC. Sexual outcome after epilepsy surgery. Epilepsy Behav.4268–4278 (2003).
   Google Scholar
• Herzog AG, Coleman AE, Jacobs AR et al. Relationship of sexual dysfunction to epilepsy laterality and reproductive hormone levels in women. Epilepsy Behav.4, 407–413 (2003).
   PubMed Web of Science ®Google Scholar
• Herzog AG, Schachter SC. On the association between valproate and polycystic ovary syndrome Epilepsia42, 311–315 (2001).
   PubMed Web of Science ®Google Scholar
• Kalinin VV, Zheleznova EV. Chronology and evolution of temporal lobe epilepsy and endocrine reproductive dysfunction in women: relationships to side of focus and catameniality. Epilepsy Behav.11, 185–191 (2007).
   PubMed Web of Science ®Google Scholar
• Harden CL. Sexual dysfunction in women with epilepsy. Seizure17, 131–135 (2008).
   PubMed Web of Science ®Google Scholar
• Crawford P, Appleton R, Betts T, Duncan J, Guthrie E, Morrow J. Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development group. Seizure8, 201–217 (1999).
   PubMed Web of Science ®Google Scholar
• Bauer J, Burr W, Elger CE. Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy: a prospective study. Eur. J. Neurol.5, 83–88 (1998).
   PubMed Web of Science ®Google Scholar
• Morrell MJ, Sperling MR, Stecker M, Dichter MA. Sexual dysfunction in partial epilepsy: a deficit in physiologic sexual arousal. Neurology44, 243–247 (1994).
   PubMed Web of Science ®Google Scholar
• Bauer J, Cooper-Mahkorn D. Reproductive dysfunction in women with epilepsy: menstrual cycle abnormalities, fertility, and polycystic ovary syndrome. Int. Rev. Neurobiol.83, 135–155 (2008).
   PubMed Web of Science ®Google Scholar
• Manna I, Labate A, Gambardella A et al. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Neurosci. Lett.421, 52–56 (2007).
   PubMed Web of Science ®Google Scholar
• Dana-Haeri J, Oxley J, Richen A. Reduction of free testosterone by antiepileptic drugs. Br. Med. J.284, 85–86 (1982).
   PubMed Web of Science ®Google Scholar
• Beastall GH, Cowan RA, Gray JM, Fogelman I. Hormone binding globulins and anticonvulsant therapy. Scott. Med. J.30, 101–105 (1985).
   PubMed Web of Science ®Google Scholar
• Victor A, Lundberg PO, Johansson ED. Induction of sex hormone binding globulin by phenytoin. Br. Med. J.2, 934–935 (1977).
   PubMed Web of Science ®Google Scholar
• Levesque LA, Herzog AG, Seibe MM. The effect of phenytoin and carbamazepine on serum dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. J. Clin. Endocrinol. Metab.63, 243–245 (1986).
   PubMed Web of Science ®Google Scholar
• Galimberti CA, Magri F, Copello F et al. Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency. Epilepsia50, 28–32 (2009).
   PubMed Web of Science ®Google Scholar
• Murialdo G, Galimberti CA, Gianelli MV et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin. Neuropharmacol.21, 52–58 (1998).
   PubMed Web of Science ®Google Scholar
• Herzog AG. Disorders of reproduction in patients with epilepsy: primary neurological mechanisms. Seizure17, 101–110 (2008).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI. Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy. Epilepsia31(4), 438–445 (1990).
   PubMed Web of Science ®Google Scholar
• Galimberti CA, Magri F, Copello F et al. Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment. Epilepsia46, 517–523 (2005).
   PubMed Web of Science ®Google Scholar
• Mejias-Aponte CA, Jimenz-Rivera CA, Segarra AC. Sex differences in models of temporal lobe epilepsy: role of testosterone. Brain Res.944, 210–218 (2002).
   PubMed Web of Science ®Google Scholar
• Jacobsen NW, Halling-Sorensen B, Birkved K. Inhibition of human aromatase complex (CYP19) by antiepileptic drugs. Toxicol. In Vitro22, 146–143 (2008).
   PubMed Web of Science ®Google Scholar
• Taubøll E, Gregoraszczuk LE, Wojtowicz AK, Milewicz T. Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells. Epilepsia50, 1868–1874 (2009).
   PubMed Web of Science ®Google Scholar
• Murialdo G, Galimberti CA, Magri F et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J. Endocrinol. Invest.20, 519–526 (1997).
   PubMed Web of Science ®Google Scholar
• Rättyä J, Pakarinen AJ, Knip M et al. Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology57, 440–444 (2001).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. Menstrual disorders in women with epilepsy receiving carbamazepine. Epilepsia36, 676–681 (1995).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann. Neurol.39, 579–584 (1996).
   PubMed Web of Science ®Google Scholar
• Lossius MI, Taubøll E, Mowinckel P, Mørkrid L, Gjerstad L. Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy – a prospective randomized double-blind withdrawal study. Epilepsia48, 1875–1882 (2007).
   PubMed Web of Science ®Google Scholar
• Dana-Haeri J, Oxley J, Richens A. Pituitary responsiveness to gonadotrophin-releasing and thyrotrophin-releasing hormones in epileptic patients receiving carbamazepine or phenytoin. Clin. Endocrinol. (Oxf.)20, 163–168 (1984).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Myllylä VV, Pakarinen AJ. Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patients. Epilepsia30, 50–56 (1989).
   PubMed Web of Science ®Google Scholar
• Bonuccelli U, Murialdo G, Martino E et al. Effects of carbamazepine on prolactin secretion in normal subjects and in epileptic subjects. Clin. Neuropharmacol.8, 165–174 (1985).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Taubøll E, Pakarinen AJ et al. Altered ovarian function and cardiovascular risk factors in valproate-treated women. Am. J. Med.111, 290–296 (2001).
   PubMed Web of Science ®Google Scholar
• Bauer J, Jarre A, Klingmüller D, Elger CE. Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Res.41, 163–167 (2000).
   PubMed Web of Science ®Google Scholar
• Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie MJ. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia42, 1002–1006 (2001).
   PubMed Web of Science ®Google Scholar
• Betts T, Yarrow H, Dutton N, Greenhill L, Rolfe T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure12, 323–329 (2003).
   PubMed Web of Science ®Google Scholar
• Prabhakar S, Sahota P, Kharbanda PS et al. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study. Epilepsia48, 1371–1377 (2007).
   PubMed Web of Science ®Google Scholar
• Morrel M, Bhatt M, Ozkara C et al. Higher incidence of symptoms of polycystic ovary syndrome in women with epilepsy treated with valproate versus lamotrigine. Neurology64, 428 (2005).
   PubMed Web of Science ®Google Scholar
• Kwan P, Yip FP, Hui AC et al. Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study. Epilepsy Behav.14, 610–616 (2009).
   PubMed Web of Science ®Google Scholar
• Stephen LJ, Sills GJ, Leach JP et al. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy. Epilepsy Res.75, 122–129 (2007).
   PubMed Web of Science ®Google Scholar
• Vainionpää LK, Rättyä J, Knip M et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann. Neurol.45, 444–450 (1999).
   PubMed Web of Science ®Google Scholar
• Verrotti A, Ciampani M, Pomilio M, Latini G, Chiarelli F. Endocrine abormalities induced by antiepileptic drugs. Curr. Pediatr. Rev.2, 85–92 (2006).
   Google Scholar
• Death AK, McGrath KC, Handelsman DJ. Valproate is an anti-androgen and anti-progestin. Steroids70, 946–953 (2005).
   PubMed Web of Science ®Google Scholar
• Lydon JP, DeMayo FJ, Conneely OM, O’Malley BW. Reproductive phenotpes of the progesterone receptor null mutant mouse. J. Steroid Biochem. Mol. Biol.56, 67–77 (1996).
   PubMed Web of Science ®Google Scholar
• Rättya J, Vainionpää L, Knip M, Lanning P, Isojärvi JI. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics103, 588–593 (1999).
   PubMed Web of Science ®Google Scholar
• Löfgren E, Tapanainen JS, Koivunen R, Pakarinen A, Isojärvi JI. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. Epilepsia47, 1441–1446 (2006).
   PubMed Web of Science ®Google Scholar
• Isojärvi JI, Rättyä J, Myllylä VV et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann. Neurol.43, 446–451 (1998).
   PubMed Web of Science ®Google Scholar
• Morrell MJ, Isojärvi J, Taylor AE et al. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res.54, 189–199 (2003).
   PubMed Web of Science ®Google Scholar
• Opaleke A, Helmers SL. Hormonal consequences of epilepsy. Semin. Pediatr. Neurol.14, 189–195 (2007).
   PubMedGoogle Scholar
• Sahota P, Prabhakar S, Kharbanda PS et al. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study. Epilepsia49, 2069–2077 (2008).
   PubMed Web of Science ®Google Scholar
• Gorkemli H, Genc BO, Dogan E, Genc E, Ozdemir S. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy. Gynecol. Obstet. Invest.67, 223–227 (2009).
   PubMed Web of Science ®Google Scholar
• Luef G, Abraham I, Trinka E et al. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Epilepsy Res.48, 91–102 (2002).
   PubMed Web of Science ®Google Scholar
• Genton P, Bauer J, Duncan S et al. On the association between valproate and polycystic ovary syndrome. Epilepsia42, 295–304 (2001).
   PubMed Web of Science ®Google Scholar
• Luef G, Abraham I, Haslinger M et al. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. J. Neurol.249, 835–841 (2002).
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab.89, 2745–2749 (2004).
   PubMed Web of Science ®Google Scholar
• Polson DW. Polycystic ovary syndrome and epilepsy – a gynaecological perspective. Seizure12, 397–402 (2003).
   PubMed Web of Science ®Google Scholar
• Rasgon N. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J. Clin. Psychopharmacol.24, 322–334 (2004).
   PubMed Web of Science ®Google Scholar
• Duncan S. Polycystic ovarian syndrome in women with epilepsy: a review. Epilepsia42, 60–65 (2001).
   PubMed Web of Science ®Google Scholar
• Betts T, Dutton N, Yarrow H. Epilepsy and the ovary (cutting out the hysteria). Seizure10, 220–328 (2001).
   PubMed Web of Science ®Google Scholar
• Verrotti A, Basciani F, Morresi S, de Martino M, Morgese G, Chiarelli F. Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology53, 230–232 (1999).
   PubMed Web of Science ®Google Scholar
• Verrotti A, la Torre R, Trotta D, Mohn A, Chiarelli F. Valproate-induced insulin resistance and obesity in children. Horm. Res.71, 125–131 (2009).
   PubMed Web of Science ®Google Scholar
• Jallon P, Picard F. Bodyweight gain and anticonvulsants: a comparative review. Drug Saf.24, 969–978 (2001).
   PubMed Web of Science ®Google Scholar
• Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology56, 172–177 (2001).
   PubMed Web of Science ®Google Scholar
• Wirrell EC. Valproic acid-associated weight gain in older children and teens with epilepsy. Pediatr. Neurol.28, 126–129 (2003).
   PubMed Web of Science ®Google Scholar
• Mikkonen K, Vainionpää LK, Pakarinen AJ et al. Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology62, 445–450 (2004).
   PubMed Web of Science ®Google Scholar
• Egger J, Brett EM. Effects of sodium valproate in 100 children with special reference to weight. Br. Med. J.283, 577–581 (1981).
   PubMed Web of Science ®Google Scholar
• Dinesen H, Gram L, Andersen T, Dam M. Weight gain during treatment with valproate. Acta Neurol. Scand.70, 65–69 (1984).
   PubMed Web of Science ®Google Scholar
• Breum L, Astrup A, Gram L et al. Metabolic changes during treatment with valproate in humans: implication for untoward weight gain. Metab. Clin. Exp.41, 666–670 (1992).
   PubMed Web of Science ®Google Scholar
• Gidal BE, Anderson GD, Spencer NW et al. Valproate-associated weight gain: potential relation to energy expenditure and metabolism in patients with epilepsy. J. Epilepsy9, 234–241 (1996).
   Google Scholar
• Demir E, Aysun S. Weight gain associated with valproate in childhood. Pediatr. Neurol.22, 361–364 (2000).
   PubMed Web of Science ®Google Scholar
• Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia23, 693–720 (1982).
   PubMed Web of Science ®Google Scholar
• Pylvänen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojärvi JI. Serum insulin and leptin levels in valproate-associated obesity. Epilepsia,43, 514–517 (2002).
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev.18, 774–800 (1997).
   PubMed Web of Science ®Google Scholar
• Luef GJ, Lechleitner M, Bauer G, Trinka E, Hengster P. Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients. Epilepsy Res.55, 53–58 (2003).
   PubMed Web of Science ®Google Scholar
• Wong HY, Chu TS, Lai JC et al. Sodium valproate inhibits glucose transport and exacerbates Glut-1 deficiency in vitro. J. Cell. Biochem.96, 775–785 (2005).
   PubMed Web of Science ®Google Scholar
• Gregoraszczuk E, Wójtowicz AK, Taubøll E, Ropstad E. Valproate-induced alterations in testosterone, estradiol and progesterone secretion from porcine follicular cells isolated from small- and medium-sized ovarian follicles. Seizure9, 480–485 (2000).
   PubMed Web of Science ®Google Scholar
• Taubøll E, Isojärvi JI, Flinstad Harbo H, et al. Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats. Seizure8, 490–493 (1999).
   PubMed Web of Science ®Google Scholar
• Røste LS, Taubøll E, Berner A, Isojärvi JI, Gjerstad L. Valproate, but not lamotrigine, induces ovarian morphological changes in Wistar rats. Exp. Toxicol. Pathol.52, 545–552 (2001).
   PubMedGoogle Scholar
• Isojärvi J. Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure17, 111–119 (2008).
   PubMed Web of Science ®Google Scholar
• Adab N, Kini U, Vinten J et al. The long term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry75, 1575–1583 (2004).
   PubMed Web of Science ®Google Scholar
• Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. J. Perinat. Med.7, 3–6 (1979).
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and puerperium. Clin. Pharmacokinet.46, 209–219 (2007).
   PubMed Web of Science ®Google Scholar
• Teramo K, Hiilesmaa V. Pregnancy and fetal complications in epileptic pregnancies. In: Epilepsy, Pregnancy, and the Child. Janz D, Dam M, Bossi L, Helge H, Richens A, Schmidt D (Eds). Raven, NY, USA 53–59 (1982).
   Google Scholar
• The EURAP study group. Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry. Neurology66, 354–360 (2006).
   PubMed Web of Science ®Google Scholar
• Katz O, Levy A, Wizniter A et al. Pregnancy and perinatal outcome in epileptic women: a population-based study. J. Matern. Fetal Neonatal Med.19, 21–25 (2006).
   PubMed Web of Science ®Google Scholar
• Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. (2004) Epilepsy and pregnancy: an obstetric perspective. Am. J. Obstet. Gynecol.190, 371–379 (2004).
   PubMed Web of Science ®Google Scholar
• Olafsson E, Hallgrimsson JT, Hauser WA. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia39, 887–892 (1998).
   PubMed Web of Science ®Google Scholar
• Fairgrieve SD, Jackson M, jonas P et al. Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ321, 674–675 (2000).
   PubMed Web of Science ®Google Scholar
• Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia46, 117–124 (2005).
   PubMed Web of Science ®Google Scholar
• Viinikainen K, Heinonen S, Eriksson K, Kalviainen R. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia47, 186–192 (2006).
   PubMed Web of Science ®Google Scholar
• Harden LH, Hopp J, Ting YT et al. Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency. Epilepsia50, 1229–1236 (2009).
   PubMed Web of Science ®Google Scholar
• Fried S, Kozer E, Nulman I, Einarson TR, Koren G. Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf.27, 197–202 (2004).
   PubMed Web of Science ®Google Scholar
• Fonager K, Larsen H, Pedersen L, Sørensen HT. Birth outcomes in women exposed to anticonvulsant drugs. Acta Neurol. Scand.101, 289–294 (2000).
   PubMed Web of Science ®Google Scholar
• Holmes LB, Harvey EA, Coull BA et al. The teratogenicity of anticonvulsant drugs. N. Engl. J. Med.344, 1132–1138 (2001).
   PubMed Web of Science ®Google Scholar
• Kaaja E, Kaaja R, Matila R, Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology58, 549–553 (2002).
   PubMed Web of Science ®Google Scholar
• Sabers A, Dam M, Rogvi-Hansen B, Boas J, Sidenius P, Laue FM. Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol. Scand.10, 9–13 (2004).
   Google Scholar
• Aguglia U, Barboni G, Battino D et al. Italian Consensus Conference on Epilepsy and Pregnancy, Labor and Puerperium. Epilepsia50, 7–23 (2009).
   PubMed Web of Science ®Google Scholar
• Tomson T. Gender aspects of pharmacokinetics of new and old AEDs: pregnancy and breast-feeding. Ther. Drug Monit.27, 718–721 (2005).
   PubMed Web of Science ®Google Scholar
• Veiby G, Daltveit KA, Engelsen AB, Gilhus EN. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia50, 2130–2139 (2009).
   PubMed Web of Science ®Google Scholar
• Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology64, 1874–1878 (2005).
   PubMed Web of Science ®Google Scholar
• Vajda FJ, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol. Scand.112, 137–143 (2005).
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry77, 193–198 (2006).
   PubMed Web of Science ®Google Scholar
• Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr.9, 174–176 (2004).
   Google Scholar
• Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology64, 961–965 (2005).
   PubMed Web of Science ®Google Scholar
• Barrett C, Richens A. Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Res.52, 147–187 (2003).
   PubMedGoogle Scholar
• Olafsson E, Hauser WA, Gudmundsson G. Fertility in patients with epilepsy: a population-based study. Neurology51, 71–73 (1998).
   PubMed Web of Science ®Google Scholar
• Harden CL. Sexuality in women with epilepsy. Epilepsy Behav7, S2–S6 (2005).
   PubMed Web of Science ®Google Scholar
• Bauer J, Stefan H, Schrell U, Sappke U, Uhlig B. Neurophysiologic principles and clinical value of post-convulsive serum prolactin determination in epileptic seizure. Fortschr. Neurol. Psychiatr.57, 457–468 (1989).
   PubMed Web of Science ®Google Scholar
• Bauer J. Epilepsy and prolactin in adults: a clinical review. Epilepsy Res.24, 1–7 (1996).
   PubMed Web of Science ®Google Scholar
• Duncan S, Blacklaw J, Beastall GH, Brodie MJ. Sexual function in women with epilepsy. Epilepsia38, 1074–1081 (1997).
   PubMed Web of Science ®Google Scholar
• Morrell MJ, Guldner GT. Self-reported sexual function and sexual arousability in women with epilepsy. Epilepsia37, 1204–1210 (1996).
   PubMed Web of Science ®Google Scholar